WallStreetZenWallStreetZen

NYSE: HAE
Haemonetics Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

HAE past earnings growth

How has HAE's earnings growth performed historically?
Company
32.98%
Industry
27.37%
Market
104.85%
HAE's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
HAE's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
HAE's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

HAE past revenue growth

How has HAE's revenue growth performed historically?
Company
12.48%
Industry
7.76%
Market
17.15%
HAE's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
HAE's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
HAE's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

HAE earnings and revenue history

Current Revenue
$1.3B
Current Earnings
$126.6M
Current Profit Margin
10%
HAE's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

HAE Return on Equity

Current Company
14.4%
Current Industry
11.1%
Current Market
188%
HAE's Return on Equity (14.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when HAE announces earnings.

HAE Return on Assets

Current Company
6.2%
Current Industry
7.2%
HAE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

HAE Return on Capital Employed

Current Company
8.78%
Current Industry
9.7%
HAE's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

HAE vs Medical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
HAE$1.27B$263.63M$126.57M+5.94%+22.94%
MMSI$1.26B$228.89M$94.41M+7.33%+15.44%
NVST$2.57B$171.10M-$100.20M-2.04%N/A
BLCO$4.15B$487.00M-$260.00M+2.35%N/A
AZTA$641.02M$55.42M-$18.75M-0.83%N/A
View Top Medical Stocks

HAE earnings dates

Next earnings date
May 9, 2024

Haemonetics Earnings & Revenue FAQ

What were HAE's earnings last quarter?

On Invalid Date, Haemonetics (NYSE: HAE) reported Q4 2023 earnings per share (EPS) of $0.62, up 4.62% year over year. Total Haemonetics earnings for the quarter were $31.24 million. In the same quarter last year, Haemonetics's earnings per share (EPS) was $0.65.

If you're new to stock investing, here's how to buy Haemonetics stock.

What was HAE's earnings growth in the past year?

As of Q2 2024, Haemonetics's earnings has grown 32.98% year over year. This is 5.61 percentage points higher than the US Medical Instruments & Supplies industry earnings growth rate of 27.37%. Haemonetics's earnings in the past year totalled $126.57 million.

What is HAE's earnings date?

Haemonetics's earnings date is Invalid Date. Add HAE to your watchlist to be reminded of HAE's next earnings announcement.

What was HAE's revenue last quarter?

On Invalid Date, Haemonetics (NYSE: HAE) reported Q4 2023 revenue of $336.25 million up 10.14% year over year. In the same quarter last year, Haemonetics's revenue was $305.30 million.

What was HAE's revenue growth in the past year?

As of Q2 2024, Haemonetics's revenue has grown 12.48% year over year. This is 4.72 percentage points higher than the US Medical Instruments & Supplies industry revenue growth rate of 7.76%. Haemonetics's revenue in the past year totalled $1.27 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.